Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,321 papers from all fields of science
Search
Sign In
Create Free Account
Metastatic Disease Clinical Trial Setting
Known as:
METASTATIC
A clinical trial or treatment setting in which the therapy of interest is used to treat metastatic disease.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
CDISC SDTM Treatment Setting Terminology
Clinical Data Interchange Standards Consortium Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
NCI9673: A multi-institutional eETCTN phase II study of nivolumab in refractory metastatic squamous cell carcinoma of the anal canal (SCCA).
V. Morris
,
K. Ciombor
,
+17 authors
C. Eng
2016
Corpus ID: 80706765
3503Background: The incidence of SCCA continues to rise annually in the US. 20% of patients (pts) will develop metastatic (met…
Expand
2014
2014
Application of black salve to a thin melanoma that subsequently progressed to metastatic melanoma: a case study
G. Sivyer
,
C. Rosendahl
Dermatology Practical & Conceptual
2014
Corpus ID: 27147489
This is a case study of a female patient diagnosed with superficial spreading melanoma who decided to treat the lesion by the…
Expand
2013
2013
The impact of gender on outcomes in patients with metastatic urothelial carcinoma.
Lindsay Haines
,
A. Bamias
,
+8 authors
M. Galsky
Clinical Genitourinary Cancer
2013
Corpus ID: 34849974
2011
2011
Sorafenib (SOR) plus chemotherapy (CRx) for patients (pts) with advanced (adv) breast cancer (BC) previously treated with bevacizumab (BEV).
C. Hudis
,
K. Tauer
,
+13 authors
L. Schwartzberg
Journal of Clinical Oncology
2011
Corpus ID: 28537394
1009 Background: SOR, a multikinase inhibitor targeting tumor growth and angiogenesis, is indicated for adv renal and…
Expand
2011
2011
Ixabepilone, mitoxantrone, and prednisone for metastatic castration‐resistant prostate cancer after docetaxel‐based therapy
A. Harzstark
,
J. Rosenberg
,
+7 authors
E. Small
Cancer
2011
Corpus ID: 20742235
Mitoxantrone plus prednisone and ixabepilone each have modest activity as monotherapy for second‐line chemotherapy in patients…
Expand
2010
2010
Trabectedin for Metastatic Soft Tissue Sarcoma: A Retrospective Single Center Analysis
T. Schmitt
,
É. Keller
,
S. Dietrich
,
P. Wuchter
,
A. Ho
,
G. Egerer
Marine Drugs
2010
Corpus ID: 12392366
Soft tissue sarcoma (STS) comprises a large variety of rare malignant tumors. Development of distant metastasis is frequent, even…
Expand
2009
2009
3LBA SOLTI-0701: A double-blind, randomized phase 2b study evaluating the efficacy and safety of sorafenib (SOR) compared to placebo (PL) when administered in combination with capecitabine (CAP) in…
J. Baselga
,
J. Segalla
,
+7 authors
F. Costa
2009
Corpus ID: 71724709
Review
2008
Review
2008
Targeted therapies in the management of colorectal carcinoma: role of bevacizumab
A. Puthillath
,
A. Patel
,
M. Fakih
OncoTargets and Therapy
2008
Corpus ID: 3024660
Colorectal cancer continues to be an important public health concern, despite improvements in screening and better systemic…
Expand
Review
2007
Review
2007
Outcome for metastatic (M+) medulloblastoma (MB) treated with carboplatin during craniospinal radiotherapy (CSRT) followed by cyclophosphamide (CPM) and vincristine (VCR): Preliminary results of COG…
R. Jakacki
,
P. Burger
,
+5 authors
I. Pollack
2007
Corpus ID: 76222899
2017 Background: The outcome for patients with metastatic medulloblastoma has historically been poor. Carboplatin is both a…
Expand
2005
2005
Hypothyroidism may accompany SU11248 therapy in a subset of patients (pts) with metastatic (met) gastrointestinal stromal tumors (GIST) and is manageable with replacement therapy
J. Desai
,
P. Dileo
,
+6 authors
G. Demetri
2005
Corpus ID: 78539915
3040 Background: SU11248 is an oral, multitargeted kinase inhibitor with antiangiogenic and antitumor activity due to inhibition…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required